awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38071706-2A891887-5206-4A19-848C-395F08FF2DBF
Q38071706-2A891887-5206-4A19-848C-395F08FF2DBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38071706-2A891887-5206-4A19-848C-395F08FF2DBF
Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes.
P2860
Q38071706-2A891887-5206-4A19-848C-395F08FF2DBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38071706-2A891887-5206-4A19-848C-395F08FF2DBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a37f0652ef9a7a4b8dd806aecf3f3006aebb8072
P2860
Glucokinase-activating GCKR polymorphisms increase plasma levels of triglycerides and free fatty acids, but do not elevate cardiovascular risk in the Ludwigshafen Risk and Cardiovascular Health Study.